1. 刘锡光，方成.POCT基本理论和临床医学实践.北京:中国医药科技出版社，2006.

2. Philip SS，Ahrens K，shayevich C，et al.Evaluation of a New Point-of-Care Serologic Assay for Herpes Simplex Virus Type 2 Infection[J].Clinical Infectious Diseases，2008，47（10）：e79-82.

3. 李臻.非充血性心力衰竭患者B型利钠钛及其前体升高的意义[J].国际心血管病杂志，2009，36（1）:31.

4. 朱丹.炎症因子在急性冠脉综合征中的意义[J].国际心血管病杂志，2009，36（5）:257.

5. Yang Z，Min Zhou D. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. Clin Biochem，2006，39：771-780.

6. 胡大一，霍勇，马长生，等.心血管疾病防治指南和共识2007.北京:人民卫生出版社，2007:218-250.

7. Di Serio F，Lovero R，Leone M，et al. Integration between the tele-cardiology unit and the central laboratory：methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance. Clin Chem Lab Med，2006，44：768-773.

8. Kost GJ，Tran NK. Point-of-Care Testing and Cardiac Biomarkers：The Standard of Care and Vision for Chest Pain Centers. Cardiol Clin，2005，23 ：467-490.

9. Ishii J，Ozaki Y，Lu J. et al.Prognositic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem，2005，51：1397-1404.

10. Hallani H，Leung DY，Newland E，et al. Use of a quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes. Intern Med J，2005，35：560-562.

11. Azzazy HM，Christenson RH，Pelsers MM. Unbound free fatty acids and heart-type fatty acid-binding protein:diagnostic assays and clinical applications. Clin Chem，2006，52：119.

12. Bhagavan NV，Lai EM，Rios PA. et al. Evaluation of human serum albumin cobalt binding assay for the assessment of ischemia and myocardial infarction. ClinChem. 2003，49，581-585.

13. Stejskal D，Lacnak B，Jedelsky L. et al. Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub，2007，151：247-249.

14. Huang PH，Lu TM，Wu TC. et al. Usefulness of combined high-sensitive C-reactive protein and N-terminalprobrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. Coron Artery Dis，2008，19 ：187-193.

15. Abi-Saleh B，Iskandar SB，Elgharib N，et al. C-reactive protein：the harbinger of cardiovascular diseases. South Med J，2008，101：525-533.

16. Collinson PO，John C，Lvnch S. et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem，2004，41：397-404.

17. Hong MK，Mintz GS，Lee CW. et al. Comparision of coronary plaque rupture between stable angina and acute myocardial infarction:a three-vessel intravascular ultrasound study in 235 patients.Circulation，2004，110：928-933.

18. Tuter G，Kurtis B，Serdar M. Evaluation of gingival crevicular fluid and serum levels of high-sensitivity C-reactive protein in chronic periodontitis patients with or without coronary artery disease. J Periodontol，2007，78：2319-2324.

19. Brennan ML，Penn MS，Lente FV，et al.Prognostic value of myeloperoxise in patients with chest pain. N Engl J Med，2003，349:1595.

20. Seino Y，Tomita Y，Takano T，et al.Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction. Comparison between heart-type fatty acid-binding protein and tropnin T test. Circ J，2004，68：144-148.

21. 张寄南，曹克将，杨志健.心脏标志物学.南京:江苏科技出版社，2007.

22. 王洁，陈健，吕元.从国际医院管理委员会认证角度谈对医院内血糖床旁检验质量管理方案[J].中华检验医学杂志，2010，33（5）:392-394.